Skip to content

Effect of Different Acupuncture Schemes for Postoperative Urinary Retention in Cervical Cancer Patients

Effect of Acupuncture at Different Combinations of Acupoints for Postoperative Urinary Retention After Radical Hysterectomy of Cervical Cancer: a Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06639399
Enrollment
73
Registered
2024-10-15
Start date
2024-12-01
Completion date
2025-10-31
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Urinary Retention (POUR)

Brief summary

This is a retrospective cohort study using a paired control design. We will review the patients of PUR after cervical cancer surgery who went to the acupuncture department and the urinary retention department in Zhejiang Cancer Hospital from October 2020 to August 2024, and 73 patients met the screening criteria. All patients provided written informed consent. The purpose of the study is to compare the effect of acupuncture at different combinations of acupoints for postoperative urinary retention (PUR) after radical hysterectomy of cervical cancer. All outcome-measures data were obtained from past medical records. It is an observational study rather than an intervention study. 73 patients met the screening criteria. They will be assigned into two groups according to the treatment scheme of acupoints combination for acupuncture: Group A (37 cases) and Group B (36 cases).

Interventions

OTHERAcupuncture

Patients received acupuncture treatment at the lumbosacral region, all acupoints belong to the bladder meridian, including Shenshu (BL23), Pangguangshu (BL28), Ciliao (BL32), Huiyang (BL35), and Zhibian (BL54) selected bilaterally. Electroacupuncture (EA) was applied to the BL32 and BL54 acupoints at a frequency of 2/100Hz. Each treatment lasting for 30 minutes. Patients received five acupuncture treatments per week for two consecutive weeks

Sponsors

Lu Chao
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18-70 years old * Karnofsky Performance Scale (KPS) score \> 70 * met the diagnostic criteria of PUR * no history of serious urinary system diseases or urinary retention before the operation * had clear cognition and no severe mental diseases * had complete medical records and records of residual urine volume data.

Exclusion criteria

* presence of other serious systemic diseases or advanced cachexia * obstructive urinary retention caused by urethral stricture, stones, or other diseases * receiving other treatments or self-change treatment * poor compliance or failure to complete the acupuncture treatments * incomplete clinical data.

Design outcomes

Primary

MeasureTime frameDescription
The change value in residual urine volumebaseline and 2 weeksResidual urine volume was assessed before the first treatment and after the final treatment by a trained outpatient nurse using a direct measurement method involving catheter insertion for urine drainage and measurement. Calculate the difference value in residual urine volume before and after treatment.

Secondary

MeasureTime frameDescription
The patient's abdominal distension sensation by the visual analog scale (VAS) methodbaseline and 2 weeksPatients were asked to mark their level of abdominal distension sensation on the line, with 0 indicating no abdominal distension and 10 indicating extremely severe abdominal distension.
The occurrence of urinary tract infectionsbaseline and 2 weeksCount the number of urinary tract infections and calculate the incidence rate
The total effective rate2 weeksClinical efficacy was assessed based on the change in residual urine volume before and after treatment. Cured: the residual urine volume was significantly decreased and less than 100 ml after treatment, and the catheter was removed with no recurrence during follow-up; Improved: the residual urine volume remained over 100 ml, but decreased by more than 100 ml compared to before treatment; Unimproved: the residual urine volume did not significantly decreased (less than 100 ml) or worsened. The total effective rate was calculated as the number of cured and improved patients divided by the total number of patients×100%.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026